Citation Impact
Citing Papers
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Hepatocellular carcinoma
2021 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
HBV-Induced Immune Imbalance in the Development of HCC
2019
Hepatocellular carcinoma
2022 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
2013
Works of Khaled Farid being referenced
Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients
2013
Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma
2016
HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
2013
Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients
2012
Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients
2011
Non‐invasive predictive score of fibrosis stages in chronic hepatitis C patients based on epithelial membrane antigen in the blood in combination with routine laboratory markers
2011
Assessment of matrix metalloproteinase-1 for marking liver cirrhosis in chronic hepatitis C patients.
2011